Inhibition of protein binding to mast cells

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S328000

Reexamination Certificate

active

07056511

ABSTRACT:
The invention relates to a compound inhibiting the binding of the free light chain of immunoglobulin (Ig LC) to mast cells. It has been found that Ig LC is the agent responsible for the sensitization of mast cells. The compounds according to the invention can thus be used for the preparation of a drug for the treatment of a disease whose symptom is an elevated Ig LC concentration in serum or spinal fluid. The invention also relates to a method of screening a series of compounds on their ability to reduce the sensitization of mast cells.

REFERENCES:
patent: 3907502 (1975-09-01), Brink
patent: 4654325 (1987-03-01), Selenke
patent: 4977244 (1990-12-01), Muchmore et al.
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Gennaro et al., in Remington's Pharmaceutical Sciences, eighteenth edition, 1990, pp. 1300-1329.
Hoppers et al., J. Clinical Immunology, Abstract, Jul. 1989, pp. 338-350, vol. 9, No. 4.
Huang et al., “Localization of a Single Binding Site for Immunoglobulin Light Chains on Human Tamm-Horsfall Glycoprotein”, The Journal of Clinical Investigation, vol. 99, No. 4, pp. 732-736, Feb. 1997.
McDonnell et al., Nature Structural Biology, May 1996, pp. 419-426, vol. 3, No. 5.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Redegeld et al., Nature Medicine epublication, Jun. 17, 2002.
Rocken et al., Nature Medicine, Jul. 2002, pp. 668-670, vol. 9, No. 7.
Van Noort et al., International Review of Cytology, 1998, pp. 127-206, vol. 178.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of protein binding to mast cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of protein binding to mast cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of protein binding to mast cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3645989

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.